Efek Kecemasan Sosial pada Pengobatan Penyakit Behçet
DOI:
https://doi.org/10.62383/vimed.v1i4.807Keywords:
social anxiety, treatment, Behçet's diseaseAbstract
Behçet's disease is a multisystem inflammatory disorder that can significantly impact patients' quality of life. This study conducts a meta-analysis aimed at elucidating the effects of social anxiety on treatment outcomes for Behçet's disease through a comprehensive synthesis of existing literature. Initially, a systematic search was performed across major electronic databases to identify relevant studies published between 2014 and 2024. Out of 1,253 initially identified articles, 18 studies met the inclusion criteria, encompassing 2,487 Behçet's disease patients. The meta-analysis revealed a significant negative correlation between social anxiety levels and treatment adherence for Behçet's disease (r = -0.42, p < 0.001), which was positively associated with disease symptom severity (g = 0.58, 95% CI [0.41, 0.75]). Moderator analysis indicated that the effect of social anxiety on Behçet's treatment outcomes was more pronounced in patients with mucocutaneous manifestations (Q = 7.23, p = 0.007). Additionally, social anxiety showed a strong negative correlation with patients' quality of life in health (r = -0.53, p < 0.001), with the most substantial impact observed in the social functioning domain. Furthermore, thematic analysis of the potential mechanisms underlying the relationship between anxiety and Behçet's treatment outcomes confirmed the mediating roles of patient-doctor communication barriers, increased stigma perception, and avoidance behaviour. These findings underscore the importance of assessing and addressing social anxiety in the comprehensive management of Behçet's disease. The researchers suggest that these findings could have implications for improving patient treatment and quality of life. Finally, the study supports the integration of targeted psychological interventions into standard care protocols for Behçet's disease and emphasizes the need for a biopsychosocial approach to managing this condition.
References
Akdeniz, N., Elmas, O. F., & Karadag, A. S. (2019). Behçet syndrome: A great imitator. Clinics in Dermatology, 37(3), 227-239.
Al-Araji, A., & Kidd, D. P. (2009). Neuro-Behçet's disease: epidemiology, clinical characteristics, and management. The Lancet Neurology, 8(2), 192–204.
Asmundson, G. J., & Katz, J. (2009). Understanding the co‐occurrence of anxiety disorders and chronic pain: state‐of‐the‐art. Depression and anxiety, 26(10), 888-901.
Borenstein, M., Hedges, L. V., Higgins, J. P., & Rothstein, H. R. (2021). Introduction to meta-analysis. John Wiley & Sons.
Calamia, K. T., & Kaklamanis, P. G. (2008). Behcet’s disease: recent advances in early diagnosis and effective treatment. Current rheumatology reports, 10(5), 349-355.
Davatchi, F., Chams-Davatchi, C., Shams, H., Shahram, F., Nadji, A., Akhlaghi, M., ... & Masoumi, M. (2017). Behcet’s disease: epidemiology, clinical manifestations, and diagnosis. Expert review of clinical immunology, 13(1), 57-65.
Direskeneli, H. (2006). Autoimmunity vs autoinflammation in Behcet's disease: Do we oversimplify a complex disorder? Rheumatology, 45(12), 1461-1465.
Esatoglu, S. N., & Hatemi, G. (2019). Update on the treatment of Behçet’s syndrome. Internal and Emergency Medicine, 14(5), 661-675.
Hatemi, G., Christensen, R., Bang, D., Bodaghi, B., Celik, A. F., Fortune, F., ... & Yazici, H. (2018). 2018 update of the EULAR recommendations for the management of Behçet’s syndrome. Annals of the rheumatic diseases, 77(6), 808-818.
Hatemi, G., Seyahi, E., Fresko, I., Talarico, R., & Hamuryudan, V. (2015). Behçet's syndrome: A critical digest of the 2014-2015 literature. Clin Exp Rheumatol, 33(6 Suppl 94), S3-14.
Karlidag, R., Unal, S. Ü. H. E. Y. L. A., Evereklioglu, C., Sipahi, B., Er, H., & Yologlu, S. (2003). Stressful life events, anxiety, depression and coping mechanisms in patients with Behçet's disease. Journal of the European Academy of Dermatology and Venereology, 17(6), 670-675.
Leccese, P., & Alpsoy, E. (2019). Behçet’s disease: an overview of etiopathogenesis. Frontiers in immunology, 10, 1067.
Mumcu, G. O. N. C. A., Inanc, N., Ergun, T., Ikiz, K., Gunes, M., Islek, U., ... & Direskeneli, H. (2006). Oral health related quality of life is affected by disease activity in Behçet's disease. Oral diseases, 12(2), 145-151.
Nair, J. R., & Moots, R. J. (2017). Behcet’s disease. Clinical medicine, 17(1), 71–77.
Ramshaw, H. J., Chavira, D. A., & Stein, M. B. (2010). Phenomenology of social anxiety disorder. Textbook of anxiety disorders, pp. 437–452.
Seyahi, E. (2016). Behçet's disease: How to diagnose and treat vascular involvement. Best practice & research Clinical rheumatology, 30(2), 279–295.
Schneider, H. J., Friedrich, N., Klotsche, J., Pieper, L., Nauck, M., John, U., ... & Wittchen, H. U. (2010). The predictive value of different measures of obesity for incident cardiovascular events and mortality. The Journal of Clinical Endocrinology & Metabolism, 95(4), 1777-1785.
Shah, A., Banner, N., Heginbotham, C., & Fulford, B. (2014). 7. American Psychiatric Association (2013) Diagnostic and Statistical Manual of Mental Disorders, 5th ed. American Psychiatric Publishing, Arlington, VA. 8. Bechara, A., Dolan, S. and Hindes, A.(2002) Decision-making and addiction (Part II): myopia for the future or hypersensitivity to reward? Neuropsychologia, 40, 1690–1705. 9. Office of Public Sector Information (2005) The Mental Capacity Act 2005. http://www. Substance Use and Older People, 21(5), 9.
Stojanovich, L., & Marisavljevich, D. (2008). Stress as a trigger of autoimmune disease. Autoimmunity reviews, 7(3), 209-213.
Takeuchi, M., Kastner, D. L., & Remmers, E. F. (2015). The immunogenetics of Behçet's disease: A comprehensive review. Journal of autoimmunity, 64, 137-148.
Turan, B., Osar, Z., Turan, J. M., Ilkova, H., & Damci, T. (2003). Dismissing attachment and outcome in diabetes: The mediating role of coping. Journal of Social and Clinical Psychology, 22(6), 607-626.
Uğuz, F., Dursun, R., Kaya, N., & Cilli, A. S. (2007). Quality of life in patients with Behçet's disease: the impact of major depression. General Hospital Psychiatry, 29(1), 21-24.
Wells, G. A., Shea, B., O’Connell, D., Peterson, J., Welch, V., Losos, M., & Tugwell, P. (2000). The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses.
Yazici, H., Seyahi, E., Hatemi, G., & Yazici, Y. (2018). Behçet syndrome: a contemporary view. Nature Reviews Rheumatology, 14(2), 107-119.
Lin, Y., Cai, H., Liu, H. H., Su, X. J., Zhou, C. Y., Li, J., ... & Xiang, Y. T. (2023). Prevalence of depression and its association with quality of life in patients after pacemaker implantation during the COVID-19 pandemic: A network analysis. Frontiers in Psychiatry, 14, 1084792.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2024 Vitalitas Medis : Jurnal Kesehatan dan Kedokteran
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
